Pharmacy Podcast Network

Medical Affairs with Irene von Hennigs | DarshanTalks

Medical Affairs will be discussed in this episode of the DarshanTalks podcast. Host Darshan Kulkarni welcomes guest Irene von Hennigs. Irene von Hennigs, Pharma D who is Vice President Medical Affairs at ChemoCentryx talks about her journey and specifically about medical affairs. She is been in the pharma industry and medical affairs for a period of 26 years. While in her consulting career she started her own company partnering with pharmaceutical companies and ChemoCentryx was one of them. There are pros and cons to consulting versus being on board, consulting business was at first for her, and held that position for about six months in ChemoCentryx. She was keen on building medical affairs and fascinated by the science of it. A pertinent question was asked - how do you build a medical affairs team? - on this, the expert answered it depends on the structures, procedures, priorities, and recruitment ( building the team and bringing in the right individuals) She mentioned the process of the structure that has been undertaken by the organization. The one-word answer was 'data', she also mentioned usage of clinical trials data and extracting it, but the prominent part is the right minds putting the effort while finding and training such minds enables building a strong team.
The complement science, also known as complement cascade, is a part of the immune system that enhances (complements) the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism, promote inflammation, or immune oneself from the infection. They then talked about building relationships and healthcare is a relationship business for eg., physician relationship with the patient, company's relationship with the physician, etc. Speaking of relationship-building she explained about the company focusing on various databases like publications, speaking engagement, medical leadership, academic institutions, centers of excellence for disease state and one can compile a list for this purpose. Collecting and forming a certain list is performed by any company however giving a human touch and tweaking the list is of utmost importance for building relationships thereon. In the mid-segment, it was asked how GDPR impacts the formation of the company, and the regulatory side was discussed. In closing, she talked about the field medical team should include the right team, the right talent, they have to have the right training and the resources to represent the company
Connect with us:
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
----
Disclaimers:
1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.
2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.
3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.
4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.
5. This does not create an attorney-client relationship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

PDS Super Conference 2022 Post-Show | Part THREE

PDS is 100% focused on equipping independent pharmacy owners with the skills they need to make their life better and their business more valuable. Each year, PDS hosts the leading independent pharmacy business conference, The PDS Super-Conference has thousands of pharmacy owners attend to discover what’s hot and what’s working right now in the industry. The Pharmacy Podcast Network was a proud media partner of the PDS 2022 Event.
Special Guests:
Sebastian Dennison
The RxDelivered Team
InView Team
Debbie Marcello - Happier at Home
Dan Benamoz, RPh
Chip Phillips
Learn more about your ad choices. Visit megaphone.fm/adchoices

Lyfe Balance with Dr. Tamar Lawful | Pharmacy Podcast Nation

LYFE Balance was founded by Dr. Tamar Lawful, PharmD, a Doctor of Pharmacy, Pharmacogenomic Specialist, Certified Ketogenic Nutrition Specialist professional. She founded LYFE Balance to help others maintain a healthy lifestyle, rebalance their health and embrace self-care; all while making it normal to Love Yourself First Every day. Integrating her love for relaxation, health and pharmacy, Tamar provides health coaching to clients who are ready to take control of their health.
 LYFE Balance is a holistic nutrition health coaching practice that re-balances lives through diet and lifestyle changes. We do not promote any one specific diet, but work with you to develop and maintain the best nutrition for your health. Everyone is different and health is not cookie-cutter. Our founding belief is that food is medicine and like medicine, food can influence your overall health.
 
Your Health Coach is a pharmacist, nutrition and genomic specialist. She will work with you to Achieve and maintain your health by using a personalized approach. Whether it be weight loss, sleep, mood or life-balance, the power to transform is in your hands.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Changing Role of the Pharmacist: Walgreen’s Dr. Rina Shah, PharmD

The role of the community pharmacist is changing as millions of Americans rely on community pharmacists to provide a new level of care during this healthcare challenged time. Independent pharmacists are able to take active roles to improve outcomes for their patients and lower costs for payers and patients alike.
Todays special guest is Dr. Rina Shah, PharmD. Rina is Group Vice President of Pharmacy Operations and Services at Walgreens. Her passion for pharmacy has been centered around transforming patient care to make an impact on patients’ lives as well as empowering those around her to do more.
In her current role, Rina leads a team that is responsible for pharmacy operations, services and specialty pharmacy across 9,000+ Walgreens pharmacies. In the last year, Rina has led Walgreens pharmacy response to COVID-19, implementing changes such as waiving prescription delivery fees, initiating proactive outreach by pharmacists to vulnerable patients, and enhancing team member and customer safety protocols. In addition to her current role, she now leads pharmacy operations for COVID-19 vaccination services.
Rina helped launch Feel More Like You in 2019, a health and beauty service available at no cost to help people living with cancer manage the medical and physical changes associated with cancer treatment. She also spearheaded the creation of a new team of dedicated pharmacists at Walgreens called Health Outcomes Pharmacists. Often outside of a traditional retail setting, these specialized pharmacists work closely with patients most at-risk of medication non-adherence to address barriers that could prevent them from taking their medications as prescribed. In 2020, Rina led the pharmacy team that secured the first enterprise-wide URAC accreditation in Specialty Pharmacy for more than 300 community-based specialty pharmacies. Often patients with life-changing health challenges need support from their pharmacy team in their local community, this accreditation assures patients of the high standards of care in place as they access their medications and understand their treatment.
She began her career at Walgreens in 1998, where she held various pharmacy roles in store. In 2007, Rina joined the corporate support center to lead several pharmacy-specific initiatives across the organization, including the launch of the Walgreens immunizations program chain-wide. The program increased immunization rates among customers covering 7 million people. She has also led sales operations and client services within market access. 
Rina was recognized by Crain’s Chicago Business as one of “40 under 40” for her leadership at Walgreens, by Fierce Healthcare as one of 2020’s Most Influential Minority Executives, and by Drug Store News as one of the Top Women in Retail for her business excellence. Rina is actively involved with the UIC College of Pharmacy, APhA, NASP, the CDC and NACDS.
She received her Doctorate in Pharmacy from the University of Illinois at Chicago in 2005.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Innovation in Pain Management with Dr. Amy Baxter, MD

The Pharmacist & Physician Opioid Collaborative
Part 5 - Pain Care Labs with Dr. Amy Baxter
Dr. Baxter directs innovation, invention, operations and strategy for Pain Care Labs. After graduating from Yale University and Emory Medical School, as a double boarded pediatric emergency physician Dr. Baxter founded PEMA Emergency Research while also founding Pain Care Labs (initially called MMJ Labs). Her contributions to science include creating and validating a pediatric pictorial nausea scale for nausea research, creating a liver enzyme algorithm to time abusive abdominal injury, creating the M-Stim platform for external pain relief, and extensive NIH scientific review group work. Accomplishments include pain and sedation textbook chapters, publications, national and international invited lectures, and testimony before HHS on the impact of needle fear on vaccination adherence; innovation impact comes from multiple NIH SBIR Fast-Tracks and patents developing Buzzy, VibraCool, and Duotherm pain relief and opioid-sparing devices.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Nitric Oxide and Sexual Health | SexPharmD

Looking for the best erectile dysfunction (ED) treatment? In this podcast, Dr. Greg McKettrick discusses the causes of ED, medication, and more.
Currently, in the United States, over 20 million men live with erectile dysfunction. A variety of factors can cause ED; however, underlying diseases are often the culprit, including: diabetes, kidney disease, neurological diseases, and vascular disease. Other lifestyle factors can increase the likelihood of ED, such as smoking, alcohol, and medications.
ED can also result from daily stressors, including anxiety, depression, and generalized anxiety. Thankfully, ED medications and treatments today are available in a variety of options.
Visit us at Stanley Specialty Pharmacy so we can find the best option for you.
Use code "SexPharmD" at www.berkeleylife.com for 10% off your first purchase.
#BerkeleyLife
Learn more about your ad choices. Visit megaphone.fm/adchoices

Lavender Oil for Anxiety. A Holistic Pharmacy Journal Club with Kari Cooney | Holistic Pharmacy Podcast

Join host Jenna Carmichael, PharmD as she discusses A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder with guest Kari Coody, PharmD.
Kari Coody is a Christian, wife, mom, Integrative Health Practitioner, Pharm D., and co-host of Take the Upgrade Podcast. Helping women prioritize their health is a real passion after seeing how broken the healthcare system is. She loves putting the pieces together and getting to the root cause of her client's issues and walking on their journey with them. Kari’s greatest role is being a wife to BJ and mom to Edy and Cooper.
Article link: https://pubmed.ncbi.nlm.nih.gov/19962288/
Silexan link: https://www.naturesway.com/products/calmaid
To learn more about our guest, Kari Coody:
Website: www.karicoody.com
IG: www.instagram.com/karicoody
Kari is also offering a free Natural Health Toolkit here: https://kari-coody.aweb.page/p/72c3dc98-a4f0-4cc9-8b05-4b7247264d67
Dr. Jenna Carmichael of Wobbly Arrow Wellness is a holistic oncology pharmacist and health coach. She works with women on the cancer journey looking for a different perspective on wellness. She combines her knowledge in the oncology space along with holistic healing methods of meditation, reiki, and yoga to help empower her clients to choose the path that works the best for their goals. She also offers genetic testing services to get a true, personalized idea of how her clients process their medications for safe and effective therapy. Go to www.wobblyarrowwellness.com to learn more about her services.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Dear American Medical Association: It’s about Public Health not a Turf War.

Dr. Scott Knoer, PharmD is the CEO of the American Pharmacists Association. Scott has been very vocal about the FDA eliminating barriers to Pharmacists prescribing COVID antivirals and how the American Medical Association (AMA) seeming to be more concerned with their 'turf' and political position compared to the benefit to public health within America.
Amesh Adalja, MD wrote in MedPage Today, an article titled: "A Successful 'Test-to-Treat' Program Requires All Hands on Deck"
Within the article, Dr. Adalja wrote. In encouraging news, President Biden just announced a new plan to increase faster access: test-to-treat. The plan will enable pharmacies to become one-stop shops for COVID-19 diagnosis and oral antiviral treatment. Having treatment available at the point-of-diagnosis has the potential to significantly improve prescribing rates, which will have the downstream impact of reducing hospitalizations. More sick patients will quickly be able to access treatment.
"We can't have a guild-like mentality that seeks to use government force to exclude qualified persons from engaging in a field for which the AMA wants physicians to be the exclusive purveyors. This has been evident in organized medicine's general opposition to expanded practice scopes for nurse practitioners, physician assistants, psychologists, and -- as is clear -- pharmacists. It's bad enough to advocate for this on a day-to-day basis. To do so during a public health emergency, where all hands are needed on deck, is destructive." -- Amesh Adalja, MD 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Law with Dr. Erin Albert, PharmD, JD | Darshan Talks

Tune into the Darshan Talks Podcast as we discuss pharmacy law. The host Darshan Kulkarni invites guest Erin Albert to share her insights, views, experiences, and much more. Erin Albert PharmD JD MBA CPBS CHVP - Edutainer, is a Kinetiq Health Pharmacy Benefit Practice Leader at Apex Benefits, Co-Host of The Point Podcast, President of American Society for Pharmacy Law.
The conversation began with the question of what is pharmacy law on which the expert explained that it is a curious intersection of pharmacists and regulatory aspects. While pharmacy is already a highly regulated industry, it offers various niches for lawyers who are now pharmacists. For example, one person might know the life sciences and regulatory aspect but completely not expertise in reimbursement. It is the broader intersection of law and the pharmacy profession.
Erin leads ASPL. ASPL is a combination of lawyers, pharmacists, and pharmacists-lawyers who like to talk about pharmacy, law, ethics, and policy that directly relate to healthcare. They are in total five hundred members associated with ASPL, an annual conference is held every year, two and half days of legal and pharmacy education. ASPL helps develop leadership, education and brings thought leaders in the space of pharmacy and law to work on a year-long project
----
Disclaimers:
1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.
2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.
3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.
4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.
5. This does not create an attorney-client relationship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Inaugural ViVE 2022 Conference in Miami - The Post Conference Show

Where there is healthcare for people's lives, Pharmacists must be present. Where were all the Pharmacists at ViVE 2022? The very first ViVE conference was absolutely amazing. ViVE created an immersive environment for interactive learning, idea generation and collaboration for the digital health community to come TogetheRx to advance healthcare. ViVE's inaugural event was on March 6-9, 2022, in Miami Beach, Florida. Where were all the #DigitalHealth Pharmacists? The Pharmacy Podcast Network will work with HLTH and ViVE to assure Pharmacists play a greater role in Tennessee at ViVE 2023. Learn more: https://www.viveevent.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices

Defining and Supporting the Professional Role of Pharmacists Associated with Traditional and Complementary Medicine

Dr. Carolina Ung of University of Macau and Dr. Joanna Harnett are conducting a study to obtain pharmacist opinions on their professional role in complementary medicines. The results of this survey will be used to inform key discussion points in a consensus process and a step towards developing an agreed and defined professional role for pharmacists in traditional and complementary medicines while establishing the support required for pharmacists to enact that role effectively. This is a public health matter implicating the quality and safe use of T&CM.  The findings of this international survey contribute to the development of an international consensus regarding:
professional role of pharmacists regarding T&CM
support required to enact the role effectively and safely
More information about the study and a link to the survey can be found here:
https://www.surveymonkey.com/r/Ph_T_CM_US_20220316
 
The study is entirely voluntary and is completed anonymously.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pennsylvanians Suffer while Pharmacy Middlemen Profit | PBM Reform Podcast Series

Pennsylvanians suffer while pharmacy middlemen profit
By Suzanna Masartis
Pennsylvanians are getting crushed by the costs they face at their neighborhood pharmacy counter. The situation has grown so bad that a shocking one in five Keystone State residents report they are unable to take their medications as prescribed due to the cost burden.[1]
As a lawmaker and an advocate who speaks to patients in Pennsylvania every day with liver disease, diabetes and other chronic conditions, I am convinced more strongly than ever that we need to reform the prescription drug supply chain.
To understand how we got here we need to understand what’s driving increasing costs. A new report found that, in 2020, manufacturers of brand-name and generic medications received only 37 cents of each dollar of the more than $680 billion spent on medications. If you look exclusively at manufacturers of brand-name medications, the drug makers are taking in just under 50 cents on the dollar. So where is the money going? Turns out that it’s little-known middlemen corporations, Pharmacy Benefit Managers (PBMs), that are taking a bigger and bigger share of the pie.[2]
PBMs were created to negotiate with insurers and drug manufacturers and establish which prescription drugs are covered by a health plan. In reality, they demand steep discounts from drug makers off of the original list price as a condition to include those drugs on the approved list of medications – and then keep the savings for themselves. But here's the real rip-off: Patients at the pharmacy counter still face co-insurance charges based on the list price -- not the discounted price insurers actually pay. In other words, PBMs are enriching themselves while hiking prices for the rest of us. {3}
Worse still, PBMs manipulate their powerful market position to reduce the availability of prescription medications by excluding them from formularies. PBMs make their money when they demand exorbitant rebates from drugmakers and charge patients full cost, meaning they prefer to include drugs with higher list prices on their formulary over an equally effective drug with a lower list price. As a result, a number of drugs are excluded from formularies because PBMs can’t make as much money from them. In 2020, the three largest PBMs excluded 846 FDA-approved drugs, denying patients access to more medications than ever before.
This market manipulation has disastrous results for patients. A study published last year found that these practices, called “drug utilization management,” can lead patients to abandon their prescribed medications and delay treatment. Approximately 20% of prescriptions in the U.S. are never filled, according to the study.[4] This outcome is simply unacceptable, and our leaders need to take action.
Congress needs to ensure that any attempt to rein in out-of-pocket prescription drug costs includes taking a close and hard look at PBMs. Doing so would go a long way toward ensuring every patient and healthcare consumer in our state can access and afford to take their medications as prescribed by their doctor.
Suzanna Masartis of Pittsburgh is the CEO of the Community Liver Alliance.
[1]https://www.healthcarevaluehub.org/advocate-resources/publications/pennsylvania-residents-worried-about-high-drug-costs-support-range-government-solutions
[2]https://ecommunications.thinkbrg.com/44/2328/uploads/brg-pharmaceutical-supply-chain-2022.pdf?intIaContactId=24HydQaSTYqd85tTztTDcQ%3d%3d&intExternalSystemId=1
[3] https://www.fiercehealthcare.com/payer/study-drug-utilization-costs-health-industry-93b-a-year-patients-bearing-most-cost
[4] https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2021.00036
Learn more about your ad choices. Visit megaphone.fm/adchoices

Seizure Clusters: A Review of New Drug Delivery Methods and Emerging Therapy Options | PTCE Pharmacy Connect

Educational Objectives
Examine challenges in current treatment options for seizure clusters, including efficacy and safety, and differentiating routes of administration
Highlight considerations in treatment of seizure clusters, including addressing barriers to treatment and providing patient counseling to improve outcomes
Faculty:
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM 
Professor
Departments of Pharmacotherapy & Outcomes Science and Neurosurgery
Virginia Commonwealth University, Medical College of Virginia
Richmond, Virginia
Neurocritical Care Clinical Pharmacist
Virginia Commonwealth University Health
Richmond, Virginia
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Department of Defense
Consultant: UCB, Chiesi, Marinus, Alexion, Ceribell
Speakers Bureau: UCB, Chiesi
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-129-H01-P. The activity is available for CE credit through March 31, 2023.
This activity is supported by an educational grant from Neurelis Inc.
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus. She is a Past President of the Neurocritical Care Society. Dr. Brophy’s research interests include neuropharmacotherapy, traumatic brain injury, biomarkers, hemostasis, stroke, and status epilepticus.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pittsburgh Pharmacy Business Innovators | RxInfluencers

Pittsburgh Headquartered based Pharmacy Podcast Network welcomes 3 Pittsburgh Pharmacy Business Innovators. 
Todd Eury welcomes Dr. Kyle McCormick to an interesting discussion with fellow pharmacy owners Shawn Nairn and Chris Antypas. Payment model changes, PBM Reform, Cost-plus pricing strategies, and some surprise growth announcements --all part of this dynamic conversation. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Successful Nutritional Supplements Business in Your Pharmacy | Pharmacy Crossroads

Two accomplished professionals share insights into key things to look for, and to do, have a successful nutritional supplement business in your pharmacy. Dennis Song, R.Ph. and owner of Flower Mound Pharmacy in Flower Mound, Texas is doing remarkable things. Critical to his success, he says, is working closely with prescribers and finding ways for nutraceuticals to become part of their prescribing habits. Getting out of the pharmacy and taking at community events is also a key aspect of success. Mike Ewers, CEO of Medella Springs provides an “insider's” view of the way his company decides which products they can produce that meet a need in the consumer market place and how clinical and functional trials help them produce products that deliver on their promise. At the end of the day, Song says there is a need for pharmacists to get more involved in helping people prevent illness.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect

Educational Objectives
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry 
Department of Pharmacy 
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.
This activity is supported by an educational grant from Supernus.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Digital Health with Bakul Patel | Darshan Talks

In this episode of the DarshanTalks Podcast, we have a discussion about Digital Health with Bakul Patel, Director, Digital Health Center of Excellence of US FDA department. He has over 28 years of leadership, business development, marketing, product management, assessing long and short-term needs, establishing objectives, improving organizational performance, and resource management. Expertise in medical device regulations, product development processes, software engineering, embedded systems, wireless communication systems, and robotics and control systems. Masters in Electronics Engineering, MBA in International Business. Six Sigma, Black-belt certified. With all the bucket of knowledge of digital health, the conversation started off with FDA going through massive changes currently. He explains his area of work in the digital health technology sphere and leading digital health with no jurisdiction boundaries, as this sector is wide in nature, and he further explains how it's always been fun to work in such an atmosphere. When it comes down to FDA there are portions of that spectrum of digital health as it may be general wellness. According to the expert, digital health is a spectrum, a continuum, a journey for an individual and purview under FDA's jurisdiction. The focus of the conversation was on the department that the expert works and the people who don't know much about can reach out to the department for advice, suggestions, reviews or portions of review depending on the products that come to different parts of the agency. There are some policy challenges, he emphasised on FDA needs to start evolving that their agency have been actively working on with other parts of the agency. Recent guidance on digital health tech in clinical trials was launched by his department and he described all the related information and implications in this podcast.
----
Disclaimers:
1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.
2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.
3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.
4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.
5. This does not create an attorney-client relationship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

An Insider Discusses How Government Affairs Work Affects Your Pharmacy | Pharmacy Crossroads

If you have ever wondered what government affairs executives do and how they affect the practice of pharmacy then you’ll want to spend 35 minutes listening to this episode. Mark Kinney, a pharmacist, has more spent more than 30 years meeting with elected officials and other influential officials to help them better understand the complex and important role pharmacy owners play in our society. And, as you’ll learn in this podcast, government affairs work goes far beyond PBM and DIR fee battles.  
 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical Decision Support Software: A Key Tool for Optimizing Population Health Level Pharmacogenomics Programs | PGx For Pharmacist

Episode Description:
On this episode, Dr. Jeffrey Shaman, Chief Science Officer at Coriell Life Sciences, and I discuss the importance of population health level pharmacogenomics versus one time pharmacogenomics tests and how clinical decision support software that integrates pharmacogenomics data into patients’ medication therapy management is a key tool to optimize population health level pharmacogenomics programs.
References:
1. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program https://www.mdpi.com/2075-4426/12/3/421
2. Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report https://www.cureus.com/articles/81096-idiopathic-symptoms-resolved-by-pharmacogenomics-enriched-comprehensive-medication-management-a-case-report
3. Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry https://www.coriell.com/resources/consequences-of-cyp2d6-copy-number-variation-for-pharmacogenomics-in-psychiatry/
4. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978656/
5. ASP Establishes March 24th as National Adverse Drug Event Awareness Day https://www.stopadr.org/blog/asp-establishes-march-24-as-national-adverse-drug-event-awareness-day-launches-awareness-campaign
Guest’s Bio:
Jeffrey A. Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences (CLS), an international leader in precision medicine. Leveraging extensive experience in genetics and pharmacology, he is a leading expert in the rapidly evolving field of pharmacogenomics (PGx), the study of how an individual’s DNA impacts his or her response to medication. Most importantly, Dr. Shaman plays a critical role in bridging the gap between genetic science and clinical application. This includes translating decades of cutting-edge genetic research into actionable insights on the safest and most effective medications for individuals based on their unique DNA and dozens of other factors.
Driven to advance public health, Dr. Shaman is focused on enabling the delivery of personalized medicine at scale and empowering the most precise medical care worldwide. He consults with large employers, public and private payer organizations, healthcare systems, academic institutions, and laboratories around the globe, advising them on how to eliminate trial-and-error prescribing, improve population health, and control rising healthcare costs
Dr. Shaman is dedicated to setting the industry standard for PGx and pioneering new advancements in the field. Along with his team, he actively researches and presents findings in top peer-reviewed journals and at leading industry events. He is an active member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, Personalized Medicine Coalition (PMC), Pharmacogenomics Global Research Network (PGRN), and other organizations.
Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.
Learn more about your ad choices. Visit megaphone.fm/adchoices

DIRs, Clawbacks, & Opacity: CMS’ Drug Pricing Debacle | The PUTTcast

The unethical business practices by PBMs when it comes to our nation's seniors run the gamut from unreasonable fees and metrics to underhanded pricing models and what could easily be considered larceny against taxpayers. Join PUTTcast co-hosts Monique Whitney and Lauren Young, with special guests Tim Hamrick and Greg Reybold of APCI to discuss the results of their explosive 3Axis study, possible outcomes of the proposed CMS rule change, and why moving prescription drug plans to a NADAC pricing model is so important for lowering costs and increasing transparency.
Learn more about your ad choices. Visit megaphone.fm/adchoices